Back to School: How biopharma can reboot drug development. Access exclusive analysis here

MVA nef: Phase II data

In a single-blind, German Phase II trial in 77 patients,

Read the full 105 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE